Background: The aim in defining the dose of HHD is to provide sufficient dialysis required to possibly ‘normalize' all abnormalities associated with renal failure in order improve patient survival and quality of life. Much progress has been made in defining the dose required to accomplish this goal, but the evidence is still far from robust. The main limitations are incomplete understanding of uremic toxins, their relative importance in causing uremic symptoms, and our inability to comprehensively assess dry weight. Summary: This review provides guidance on realistic dosing of dialysis for the HHD patient based on the available evidence, where available, and alternative regimens that suit the individual's lifestyle and preferences. Key Messages: HHD can easily accommodate alternative, intensive HD prescriptions, including daily and nocturnal HD. HHD provides prescription flexibility to fulfill patient needs while taking their preferences into account.

Keywords:
Home hemodialysis, Hemodialysis prescription, Dialysis dosing, Quality of life
1.
US Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, 2013.
2.
Rocco MV, Lockridge RS, Beck GJ, et al: The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011;80:1080-1091.
3.
Chertow GM, Levin NW, Beck GJ, et al: In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010;363:2287-2300.
4.
Diaz-Buxo JA, White SA, Himmele R: Frequent hemodialysis: a critical review. Semin Dial 2013;26:578-589.
5.
Hakim RM, Saha S: Dialysis frequency versus dialysis time, that is the question. Kidney Int 2014;85:1024-1029.
6.
Lowrie EG, Laird NM, Parker TF, et al: Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-1181.
7.
Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534.
8.
Eknoyan G, Beck GJ, Cheung AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
9.
Gilmore J: KDOQI clinical practice guidelines and clinical practice recommendations 2006 updates. Nephrol Nurs J 2006;33:487-488.
10.
Gotch FA: The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13(suppl 6):10-14.
11.
Fagugli RM, De Smet R, Buoncristiani U, et al: Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 2002;40:339-347.
12.
Duranton F, Cohen G, De Smet R, et al: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012;23:1258-1270.
13.
Cornelis T, van der Sande FM, Eloot S, et al: Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study. Am J Kidney Dis 2014;62:247-256.
14.
Daugirdas JT, Chertow GM, Larive B, et al: Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol 2012;23:727-738.
15.
Velasco N, Chamney P, Wabel P, et al: Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients. Hemodial Int 2012;16:465-472.
16.
Santos SF, Peixoto AJ: Sodium balance in maintenance hemodialysis. Semin Dial 2010;23:549-555.
17.
Tomita M, Malhotra D, Dheenan S, et al: A potential role for immune activation in hemodialysis hypotension. Ren Fail 2001;23:637-649.
18.
Jefferies HJ, Virk B, Schiller B, et al: Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011;6:1326-1332.
19.
Yuen D, Richardson RM, Fenton SS, et al: Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J 2005;51:236-241.
20.
Rocco MV: Does more frequent hemodialysis provide dietary freedom? J Ren Nutr 2013;23:259-262.
21.
Demirci C, Ozkahya M, Demirci MS, et al: Effects of three times weekly eight-hour nocturnal hemodialysis on volume and nutritional status. Am J Nephrol 2013;37:559-567.
22.
Weinhandl ED, Nieman KM, Gilbertson DT, et al: Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis 2014, DOI: 10.1053/j.ajkd.2014.06.015, Epub ahead of print.
23.
Johansen KL, Zhang R, Huang Y, et al: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009;76:984-990.
24.
Bergman A, Fenton SS, Richardson RM, et al: Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol 2008;69:33-39.
25.
Tennankore K, Nadeau-Fredette AC, Chan CT: Intensified home hemodialysis: clinical benefits, risks and target populations. Nephrol Dial Transplant 2014;29:1342-1349.
26.
Buoncristiani U: Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 1998;13(suppl 6):148-151.
27.
Blagg CR, Kjellstrand CM, Ting GO, et al: Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Hemodial Int 2006;10:371-374.
28.
Weinhandl ED, Liu J, Gilbertson DT, et al: Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol 2012;23:895-904.
29.
Nesrallah GE, Lindsay RM, Cuerden MS, et al: Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 2012;23:696-705.
30.
Lockridge RS, Kjellstrand CM: Nightly home hemodialysis: outcome and factors associated with survival. Hemodial Int 2011;15:211-218.
31.
Marshall MR, Hawley CM, Kerr PG, et al: Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis 2011;58:782-793.
32.
Woods JD, Port FK, Stannard D, et al: Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 1996;49:1464-1470.
33.
White RD: Patient empowerment and optimal glycemic control. Curr Med Res Opin 2012;28:979-989.
34.
Cafazzo JA, Leonard K, Easty AC, et al: Patient perceptions of remote monitoring for nocturnal home hemodialysis. Hemodial Int 2010;14:471-477.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.